In addition to genetic mutations in DNMT3A, we show that DNMT3A suppression in T-ALL cells by alternative mechanisms (Figure 6D) also confers sensitivity to RUX (Figure 6E), potentially expanding the T-ALL population that may benefit from JAK/STAT inhibition. Here, DNMT3A is linked to acute lymphoblastic leukemia.